课题基金 / 基金详情

Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice

Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
使用易患癌症的基因工程小鼠研究癌症预防和进展治疗的体内评价系统
批准号:
12558097
负责人:
OHNISHI Yasuyuki
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

OHNISHI Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了利用致癌基因工程小鼠建立肿瘤预防和进展治疗的体内评价系统。我们一直在研究利用携带人类原型H-ras癌基因的rasH2转基因小鼠进行致癌性测试的模型。在这项研究中,我们建立了乌拉坦诱导的肺癌模型,致瘤性非常快。我们将这种易患癌症的小鼠系统应用于评估用于癌症预防或预防癌症进展的药物或治疗方案,如化学预防。rasH2小鼠被注射乌拉坦诱发肺癌。在乌拉坦注射后或注射前,将IL-6相关基因复合体(IL-6、IL-6受体和gp130)攻击小鼠。在乌拉坦和氨基甲酸乙烯酯(Vc,乌拉坦的近端致癌物)诱发的小鼠肺肿瘤中,导入人H-ras基因的突变分析表明,IL-6相关基因复合体具有化学预防作用。结果表明,几乎所有肿瘤都存在H-ras基因第61位密码子突变。这些结果表明,转基因61位密码子的点突变在VC和氨基甲酸乙酯诱发的rasH2小鼠肺癌的发生中起重要作用。
英文摘要
We studied to establish in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice. We have been studying carcinogenicity testing model using rasH2 transgenic mice harboring human prototype H-ras oncogene. In this study, we established urethane-induced lung cancer model with very rapid tumorigenicity. We applied this cancer prone mice system for evaluation of drug or treatment protocol for cancer protection or prevention of cancer progression such as chemoprevention.The rasH2 mice were injected urethane to induce lung tumor. After or before urethane injection, IL-6 related gene complex (IL-6, IL-6 receptor and gp130) was challenged into the mice. The incidence of lung tumor formation in the urethane injected rasH2 mice was clearly reduced, meaning the IL-6 related gene complex has chemoprevention effects.The mutational analyses of introducing human H-ras were performed in the lung tumor which induced by urethane and vinylcarbamate (VC, proximal carcinogen of urethane). The results showed almost all tumors had mutation at the 61st codon of H-ras. These results suggested that point mutations at codon 61 of the transgene play an important role in the carcinogenesis of VC- and urethane- induced lung tumors in rasH2 mice.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
Maruyama, C: "Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice"Oncol.Rep.. 8. 233-237 (2001)
Maruyama, C:“人类 H-ras 转基因的过度表达是导致小鼠化学致癌物诱发肿瘤的原因”Oncol.Rep.. 8. 233-237 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Birumachi, J.: "Diesel exhaust-induced airway hyperresponsiveness in c-Ha-ras transgenic mice"Toxicology. 163. 145-152 (2001)
Birumachi, J.:“柴油机尾气引起 c-Ha-ras 转基因小鼠气道高反应性”毒理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zembutsu H.: "Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs."Cancer Res.. 62. 518-527 (2002)
Zembutsu H.:“全基因组 cDNA 微阵列筛选,将基因表达谱与 85 个人类癌症异种移植物对抗癌药物的敏感性相关联。”Cancer Res.. 62. 518-527 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Chulan, S.a: "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines"Oncol. Rep.. 58. 89-92 (2001)
Chulan, S.a:“15 种人类胰腺癌细胞系中 K-ras、p53、p16 和 SMAD4 基因突变的特征”Oncol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    Establishment of human tumor xenotransplantation models as a pre-clinical assisting tool for translational research
    • 批准号:
      13480283
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      2001
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Knock-down mouse, a novel gene engineering mouse for use as a disease model
    • 批准号:
      11480251
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Improvement of human tumor xenograft-mouse model as a preclinical evaluation system of new drugs discovered and developed by the novel strategy against cancer
    • 批准号:
      08458278
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.73万
    • 财政年份:
      1996
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    A new approach for prediction of clinical efficacy of anticancer drugs based on toxicokinetic and pharmacokinetic analysis
    • 批准号:
      07558117
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $5.31万
    • 财政年份:
      1995
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    国内基金
    海外基金
    早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
    七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
    • 批准号:
      JCZRLH202601296
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
    • 批准号:
      JCZRLH202600985
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
    • 批准号:
      JCZRLH202601410
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: